Work

Abstract B038: KROS 101: A Next-Generation GITR Agonist Boosting Anti-Tumor T Cell Responses and Reprogramming the Tumor Microenvironment

Year: 2025

Type: conference-abstract

Source: Cancer Immunology Research

DOI: 10.1158/2326-6074.io2025-b038

Authors: Tesfahun Admasu, John S Yu

Institution: Cedars-Sinai Medical Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4407863560

Cites:

Cited by:

Related to: 10